In the United States, Medicare is a single-payer, national social insurance program administered by the U.S. federal government since 1966, currently[when?] using about 30–50 private insurance companies across the United States under contract for administration.[1][not in citation given] United States Medicare is funded by a payroll tax, premiums and surtaxes from beneficiaries, and general revenue. […]

Lab industry hopes to keep Medicare lab fee schedule cuts from causing major financial chaos Only a few months remain before it hits: the single most financially-disruptive event in the clinical lab industry in two decades. CMS will make Medicare lab fee schedule cuts deep enough to impact the entire healthcare system. In this exclusive […]

Medicare Clinical Laboratory Price Cuts and Cost-cutting Predicted to be 2018’s Two Biggest Trends for Medical Laboratories in the United States   To offset the loss of revenue from the price cuts to Medicare Part B clinical laboratory tests, labs will need to aggressively—but wisely—slash costs to balance their budgets   >Any day now, Medicare […]

Five Reasons Why Retail Clinics Are a “Game-Changing” Threat to Traditional Healthcare Providers That Could Strain Clinical Laboratories and Pathologists   Research conducted by Kalorama suggests the popularity of retail clinics represents a trend towards newer healthcare models that challenge existing models of care, and which could severely impact hospitals, clinical laboratories, and pathology groups […]